NATALIE AMODEO: Open Payments
NPI 1851990667 · ST CHARLES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 43 payments from 9 companies in 2025. Trend: 2023 $157 · 2024 $818 · 2025 $1,087
Food & beverage: $1,017Education: $70
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $354 |
| AstraZeneca Pharmaceuticals LP | 13 | $287 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $163 |
| AERIN MEDICAL INC. | 1 | $74 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| Amgen Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Stryker Corporation | 1 | $29 |
| Greer Laboratories, Inc. | 1 | $27 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, AIRSUPRA, VIVAER STYLUS, CLARIFIX, Palforzia.
Industry payments across IL — which companies pay providers there.
